HSBC HOLDINGS PLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$634,849
-20.4%
20,128
-6.7%
0.00%0.0%
Q1 2023$797,325
+173.2%
21,571
+153.9%
0.00%
Q4 2022$291,842
-38.8%
8,496
-63.2%
0.00%
-100.0%
Q3 2020$477,000
+13.0%
23,091
+15.1%
0.00%0.0%
Q2 2020$422,000
+61.7%
20,069
-8.1%
0.00%0.0%
Q1 2020$261,00021,8380.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders